APO Research

APO RESEARCH · REPORT

Nicotinamide Riboside (NR)

Selected research

Market Structure

Global Nicotinamide Riboside (NR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Nicotinamide Riboside (NR) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Nicotinamide Riboside (NR) output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Nicotinamide Riboside (NR) by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Nicotinamide Riboside (NR) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotinamide Riboside (NR) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotinamide Riboside (NR) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Riboside (NR) market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotinamide Riboside (NR) Segment by Company

ChromaDex

Genex Formulas

Bontac

Tiantai Biotechnology

Zhejiang Jiahua

Shandong Tianming Pharmaceutical

Suzhou MyLand Pharm & Nutrition

EnzymeWorks

Longer Livetech

Shenzhen Ejion Biotechnology

Nicotinamide Riboside (NR) Segment by Type

Purity ≤98%

Purity >98%

Nicotinamide Riboside (NR) Segment by Application

Health Supplement

Pharmaceutical Additives

Nicotinamide Riboside (NR) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Riboside (NR) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Riboside (NR) industry.

Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) market competition landscape. Including Nicotinamide Riboside (NR) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Nicotinamide Riboside (NR) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Nicotinamide Riboside (NR) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Nicotinamide Riboside (NR) Industry Trends Table 2. Nicotinamide Riboside (NR) Industry Drivers Table 3. Nicotinamide Riboside (NR) Industry Opportunities and Challenges Table 4. Nicotinamide Riboside (NR) Industry Restraints Table 5. Global Nicotinamide Riboside (NR) Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nicotinamide Riboside (NR) Production Value Share by Manufacturers (2021-2026) Table 7. Global Nicotinamide Riboside (NR) Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Nicotinamide Riboside (NR) Production Market Share by Manufacturers Table 9. Global Nicotinamide Riboside (NR) Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Nicotinamide Riboside (NR) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nicotinamide Riboside (NR) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application Table 13. Global Nicotinamide Riboside (NR) Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Riboside (NR) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Purity ≤98% Table 17. Major Manufacturers of Purity >98% Table 18. Global Nicotinamide Riboside (NR) Production by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Nicotinamide Riboside (NR) Production by Type (2021-2026) & (Tons) Table 20. Global Nicotinamide Riboside (NR) Production by Type (2027-2032) & (Tons) Table 21. Global Nicotinamide Riboside (NR) Production Market Share by Type (2021-2026) Table 22. Global Nicotinamide Riboside (NR) Production Market Share by Type (2027-2032) Table 23. Global Nicotinamide Riboside (NR) Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Nicotinamide Riboside (NR) Production Value by Type (2021-2026) & (Tons) Table 25. Global Nicotinamide Riboside (NR) Production Value by Type (2027-2032) & (Tons) Table 26. Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2021-2026) Table 27. Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Health Supplement Table 29. Major Manufacturers of Pharmaceutical Additives Table 30. Global Nicotinamide Riboside (NR) Production by Application 2021 VS 2025 VS 2032 (Tons) Table 31. Global Nicotinamide Riboside (NR) Production by Application (2021-2026) & (Tons) Table 32. Global Nicotinamide Riboside (NR) Production by Application (2027-2032) & (Tons) Table 33. Global Nicotinamide Riboside (NR) Production Market Share by Application (2021-2026) Table 34. Global Nicotinamide Riboside (NR) Production Market Share by Application (2027-2032) Table 35. Global Nicotinamide Riboside (NR) Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Nicotinamide Riboside (NR) Production Value by Application (2021-2026) & (Tons) Table 37. Global Nicotinamide Riboside (NR) Production Value by Application (2027-2032) & (Tons) Table 38. Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2021-2026) Table 39. Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2027-2032) Table 40. ChromaDex Company Information Table 41. ChromaDex Business Overview Table 42. ChromaDex Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 43. ChromaDex Nicotinamide Riboside (NR) Product Portfolio Table 44. ChromaDex Recent Development Table 45. Genex Formulas Company Information Table 46. Genex Formulas Business Overview Table 47. Genex Formulas Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 48. Genex Formulas Nicotinamide Riboside (NR) Product Portfolio Table 49. Genex Formulas Recent Development Table 50. Bontac Company Information Table 51. Bontac Business Overview Table 52. Bontac Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 53. Bontac Nicotinamide Riboside (NR) Product Portfolio Table 54. Bontac Recent Development Table 55. Tiantai Biotechnology Company Information Table 56. Tiantai Biotechnology Business Overview Table 57. Tiantai Biotechnology Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 58. Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 59. Tiantai Biotechnology Recent Development Table 60. Zhejiang Jiahua Company Information Table 61. Zhejiang Jiahua Business Overview Table 62. Zhejiang Jiahua Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 63. Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio Table 64. Zhejiang Jiahua Recent Development Table 65. Shandong Tianming Pharmaceutical Company Information Table 66. Shandong Tianming Pharmaceutical Business Overview Table 67. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio Table 69. Shandong Tianming Pharmaceutical Recent Development Table 70. Suzhou MyLand Pharm & Nutrition Company Information Table 71. Suzhou MyLand Pharm & Nutrition Business Overview Table 72. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio Table 74. Suzhou MyLand Pharm & Nutrition Recent Development Table 75. EnzymeWorks Company Information Table 76. EnzymeWorks Business Overview Table 77. EnzymeWorks Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio Table 79. EnzymeWorks Recent Development Table 80. Longer Livetech Company Information Table 81. Longer Livetech Business Overview Table 82. Longer Livetech Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Longer Livetech Nicotinamide Riboside (NR) Product Portfolio Table 84. Longer Livetech Recent Development Table 85. Shenzhen Ejion Biotechnology Company Information Table 86. Shenzhen Ejion Biotechnology Business Overview Table 87. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 89. Shenzhen Ejion Biotechnology Recent Development Table 90. Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 91. Global Nicotinamide Riboside (NR) Production by Region (2021-2026) & (Tons) Table 92. Global Nicotinamide Riboside (NR) Production Market Share by Region (2021-2026) Table 93. Global Nicotinamide Riboside (NR) Production Forecast by Region (2027-2032) & (Tons) Table 94. Global Nicotinamide Riboside (NR) Production Market Share Forecast by Region (2027-2032) Table 95. Global Nicotinamide Riboside (NR) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 96. Global Nicotinamide Riboside (NR) Production Value by Region (2021-2026) & (US$ Million) Table 97. Global Nicotinamide Riboside (NR) Production Value Share by Region (2021-2026) Table 98. Global Nicotinamide Riboside (NR) Production Value by Region (2027-2032) & (US$ Million) Table 99. Global Nicotinamide Riboside (NR) Production Value Share by Region: (2027-2032) & (US$ Million) Table 100. Global Nicotinamide Riboside (NR) Market Average Price (US$/Ton) by Region (2021-2026) Table 101. Global Nicotinamide Riboside (NR) Market Average Price (US$/Ton) by Region (2027-2032) Table 102. Global Nicotinamide Riboside (NR) Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 103. Global Nicotinamide Riboside (NR) Consumption by Region (2021-2026) & (Tons) Table 104. Global Nicotinamide Riboside (NR) Consumption Market Share by Region (2021-2026) Table 105. Global Nicotinamide Riboside (NR) Consumption Forecasted by Region (2027-2032) & (Tons) Table 106. Global Nicotinamide Riboside (NR) Consumption Forecasted Market Share by Region (2027-2032) Table 107. North America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 108. North America Nicotinamide Riboside (NR) Consumption by Country (2021-2026) & (Tons) Table 109. North America Nicotinamide Riboside (NR) Consumption by Country (2027-2032) & (Tons) Table 110. Europe Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 111. Europe Nicotinamide Riboside (NR) Consumption by Country (2021-2026) & (Tons) Table 112. Europe Nicotinamide Riboside (NR) Consumption by Country (2027-2032) & (Tons) Table 113. Asia Pacific Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 114. Asia Pacific Nicotinamide Riboside (NR) Consumption by Country (2021-2026) & (Tons) Table 115. Asia Pacific Nicotinamide Riboside (NR) Consumption by Country (2027-2032) & (Tons) Table 116. South America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 117. South America Nicotinamide Riboside (NR) Consumption by Country (2021-2026) & (Tons) Table 118. South America Nicotinamide Riboside (NR) Consumption by Country (2027-2032) & (Tons) Table 119. Middle East & Africa Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 120. Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2021-2026) & (Tons) Table 121. Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2027-2032) & (Tons) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Nicotinamide Riboside (NR) Distributors List Table 125. Nicotinamide Riboside (NR) Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Nicotinamide Riboside (NR) Product Image Figure 2. Global Nicotinamide Riboside (NR) Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Riboside (NR) Production Value (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Riboside (NR) Production Capacity (2021-2032) & (Tons) Figure 5. Global Nicotinamide Riboside (NR) Production (2021-2032) & (Tons) Figure 6. Global Nicotinamide Riboside (NR) Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≤98% Image Figure 10. Purity >98% Image Figure 11. Global Nicotinamide Riboside (NR) Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Nicotinamide Riboside (NR) Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Nicotinamide Riboside (NR) Production Market Share by Type (2021-2032) Figure 14. Global Nicotinamide Riboside (NR) Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Nicotinamide Riboside (NR) Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nicotinamide Riboside (NR) Production Value Share by Type (2021-2032) Figure 17. Health Supplement Image Figure 18. Pharmaceutical Additives Image Figure 19. Global Nicotinamide Riboside (NR) Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Nicotinamide Riboside (NR) Production Market Share 2021 VS 2025 VS 2032 Figure 21. Global Nicotinamide Riboside (NR) Production Market Share by Application (2021-2032) Figure 22. Global Nicotinamide Riboside (NR) Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Nicotinamide Riboside (NR) Production Value Share 2021 VS 2025 VS 2032 Figure 24. Global Nicotinamide Riboside (NR) Production Value Share by Application (2021-2032) Figure 25. Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Nicotinamide Riboside (NR) Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Nicotinamide Riboside (NR) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Nicotinamide Riboside (NR) Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Nicotinamide Riboside (NR) Production Value (2021-2032) & (US$ Million) Figure 30. Europe Nicotinamide Riboside (NR) Production Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Nicotinamide Riboside (NR) Production Value (2021-2032) & (US$ Million) Figure 32. South America Nicotinamide Riboside (NR) Production Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Nicotinamide Riboside (NR) Production Value (2021-2032) & (US$ Million) Figure 34. North America Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. North America Nicotinamide Riboside (NR) Consumption Market Share by Country (2021-2032) Figure 36. U.S. Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. Canada Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. Mexico Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. Europe Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Europe Nicotinamide Riboside (NR) Consumption Market Share by Country (2021-2032) Figure 41. Germany Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. France Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. U.K. Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Italy Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Netherlands Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Asia Pacific Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Asia Pacific Nicotinamide Riboside (NR) Consumption Market Share by Country (2021-2032) Figure 48. China Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Japan Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. South Korea Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. Southeast Asia Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. India Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Australia Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. South America Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. South America Nicotinamide Riboside (NR) Consumption Market Share by Country (2021-2032) Figure 56. Mexico Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. Brazil Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. Argentina Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Middle East & Africa Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Middle East & Africa Nicotinamide Riboside (NR) Consumption Market Share by Country (2021-2032) Figure 61. Turkey Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Saudi Arabia Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. UAE Nicotinamide Riboside (NR) Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. Nicotinamide Riboside (NR) Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Nicotinamide Riboside (NR) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≤98%
  • Purity >98%
Applications
  • Health Supplement
  • Pharmaceutical Additives
Companies covered
  • ChromaDex
  • Genex Formulas
  • Bontac
  • Tiantai Biotechnology
  • Zhejiang Jiahua
  • Shandong Tianming Pharmaceutical
  • Suzhou MyLand Pharm & Nutrition
  • EnzymeWorks
  • Longer Livetech
  • Shenzhen Ejion Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Riboside (NR) Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nicotinamide Riboside (NR) Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Nicotinamide Riboside (NR) Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Nicotinamide Riboside (NR) Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Nicotinamide Riboside (NR) Market Dynamics
  1. 2.1 Nicotinamide Riboside (NR) Industry Trends
  2. 2.2 Nicotinamide Riboside (NR) Industry Drivers
  3. 2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Nicotinamide Riboside (NR) Market by Manufacturers
  1. 3.1 Global Nicotinamide Riboside (NR) Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Nicotinamide Riboside (NR) Production by Manufacturers (2021-2026)
  3. 3.3 Global Nicotinamide Riboside (NR) Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Nicotinamide Riboside (NR) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotinamide Riboside (NR) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nicotinamide Riboside (NR) Manufacturers, Product Type & Application
  7. 3.7 Global Nicotinamide Riboside (NR) Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicotinamide Riboside (NR) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3
4 Nicotinamide Riboside (NR) Market by Type
  1. 4.1 Nicotinamide Riboside (NR) Type Introduction
  2. 4.1.1 Purity ≤98%
  3. 4.1.2 Purity >98%
  4. 4.2 Global Nicotinamide Riboside (NR) Production by Type
  5. 4.2.1 Global Nicotinamide Riboside (NR) Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicotinamide Riboside (NR) Production by Type (2021-2032)
  7. 4.2.3 Global Nicotinamide Riboside (NR) Production Market Share by Type (2021-2032)
  8. 4.3 Global Nicotinamide Riboside (NR) Production Value by Type
  9. 4.3.1 Global Nicotinamide Riboside (NR) Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicotinamide Riboside (NR) Production Value by Type (2021-2032)
  11. 4.3.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Type (2021-2032)
5 Nicotinamide Riboside (NR) Market by Application
  1. 5.1 Nicotinamide Riboside (NR) Application Introduction
  2. 5.1.1 Health Supplement
  3. 5.1.2 Pharmaceutical Additives
  4. 5.2 Global Nicotinamide Riboside (NR) Production by Application
  5. 5.2.1 Global Nicotinamide Riboside (NR) Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nicotinamide Riboside (NR) Production by Application (2021-2032)
  7. 5.2.3 Global Nicotinamide Riboside (NR) Production Market Share by Application (2021-2032)
  8. 5.3 Global Nicotinamide Riboside (NR) Production Value by Application
  9. 5.3.1 Global Nicotinamide Riboside (NR) Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nicotinamide Riboside (NR) Production Value by Application (2021-2032)
  11. 5.3.3 Global Nicotinamide Riboside (NR) Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ChromaDex
  2. 6.1.1 ChromaDex Company Information
  3. 6.1.2 ChromaDex Business Overview
  4. 6.1.3 ChromaDex Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
  6. 6.1.5 ChromaDex Recent Developments
  7. 6.2 Genex Formulas
  8. 6.2.1 Genex Formulas Company Information
  9. 6.2.2 Genex Formulas Business Overview
  10. 6.2.3 Genex Formulas Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
  12. 6.2.5 Genex Formulas Recent Developments
  13. 6.3 Bontac
  14. 6.3.1 Bontac Company Information
  15. 6.3.2 Bontac Business Overview
  16. 6.3.3 Bontac Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
  18. 6.3.5 Bontac Recent Developments
  19. 6.4 Tiantai Biotechnology
  20. 6.4.1 Tiantai Biotechnology Company Information
  21. 6.4.2 Tiantai Biotechnology Business Overview
  22. 6.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  24. 6.4.5 Tiantai Biotechnology Recent Developments
  25. 6.5 Zhejiang Jiahua
  26. 6.5.1 Zhejiang Jiahua Company Information
  27. 6.5.2 Zhejiang Jiahua Business Overview
  28. 6.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
  30. 6.5.5 Zhejiang Jiahua Recent Developments
  31. 6.6 Shandong Tianming Pharmaceutical
  32. 6.6.1 Shandong Tianming Pharmaceutical Company Information
  33. 6.6.2 Shandong Tianming Pharmaceutical Business Overview
  34. 6.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
  36. 6.6.5 Shandong Tianming Pharmaceutical Recent Developments
  37. 6.7 Suzhou MyLand Pharm & Nutrition
  38. 6.7.1 Suzhou MyLand Pharm & Nutrition Company Information
  39. 6.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
  40. 6.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
  42. 6.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
  43. 6.8 EnzymeWorks
  44. 6.8.1 EnzymeWorks Company Information
  45. 6.8.2 EnzymeWorks Business Overview
  46. 6.8.3 EnzymeWorks Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
  48. 6.8.5 EnzymeWorks Recent Developments
  49. 6.9 Longer Livetech
  50. 6.9.1 Longer Livetech Company Information
  51. 6.9.2 Longer Livetech Business Overview
  52. 6.9.3 Longer Livetech Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
  54. 6.9.5 Longer Livetech Recent Developments
  55. 6.10 Shenzhen Ejion Biotechnology
  56. 6.10.1 Shenzhen Ejion Biotechnology Company Information
  57. 6.10.2 Shenzhen Ejion Biotechnology Business Overview
  58. 6.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  60. 6.10.5 Shenzhen Ejion Biotechnology Recent Developments
7 Global Nicotinamide Riboside (NR) Production by Region
  1. 7.1 Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Nicotinamide Riboside (NR) Production by Region (2021-2032)
  3. 7.2.1 Global Nicotinamide Riboside (NR) Production by Region (2021-2026)
  4. 7.2.2 Global Nicotinamide Riboside (NR) Production Forecast by Region (2027-2032)
  5. 7.3 Global Nicotinamide Riboside (NR) Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Nicotinamide Riboside (NR) Production Value by Region (2021-2032)
  7. 7.4.1 Global Nicotinamide Riboside (NR) Production Value by Region (2021-2026)
  8. 7.4.2 Global Nicotinamide Riboside (NR) Production Value by Region (2027-2032)
  9. 7.5 Global Nicotinamide Riboside (NR) Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Nicotinamide Riboside (NR) Production Value (2021-2032)
  12. 7.6.2 Europe Nicotinamide Riboside (NR) Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Nicotinamide Riboside (NR) Production Value (2021-2032)
  14. 7.6.4 South America Nicotinamide Riboside (NR) Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Nicotinamide Riboside (NR) Production Value (2021-2032)
8 Global Nicotinamide Riboside (NR) Consumption by Region
  1. 8.1 Global Nicotinamide Riboside (NR) Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Nicotinamide Riboside (NR) Consumption by Region (2021-2032)
  3. 8.2.1 Global Nicotinamide Riboside (NR) Consumption by Region (2021-2026)
  4. 8.2.2 Global Nicotinamide Riboside (NR) Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Nicotinamide Riboside (NR) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Nicotinamide Riboside (NR) Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotinamide Riboside (NR) Value Chain Analysis
  2. 9.1.1 Nicotinamide Riboside (NR) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotinamide Riboside (NR) Production Mode & Process
  6. 9.2 Nicotinamide Riboside (NR) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotinamide Riboside (NR) Distributors
  9. 9.2.3 Nicotinamide Riboside (NR) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research